September 29, 2025 · Form 4 insider transaction
Meisner Lara bought 33,807 shares of BICARA THERAPEUTICS INC at $9.24 per share, a transaction worth $312.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2024.